Treatment for laryngeal cancer 50% includes surgery, radiotherapy, chemotherapy, Chinese herbal medicine treatment, immunotherapy and so on. At present, the comprehensive therapy of surgery plus radiotherapy is mostly advocated. The selection of treatment method should be considered from various aspects, such as the primary site of tumor, extension, histological characteristics of tumor, patient’s age and physical condition, laryngeal movement, whether there are lymph node metastasis, whether the patient can be followed up regularly, etc. before deciding the treatment plan. Radical radiotherapy is only suitable for early stage (T1, T2) lesions. Such as supraglottic carcinoma limited to the epiglottis, ventricular zone or aryepiglottic folds, lesions less than 1cm in extent, without vocal fold activity restriction. Or vocal fold carcinoma limited to one side of the vocal fold or anterior union with good vocal fold motion. The total amount of radical radiotherapy should be 6000-7000cGy/6-7 weeks. There is no definite conclusion whether more than 7000 cGy can improve the cure rate, but it is known that the larger the measurement of radiotherapy, the more difficult it is to operate again when the tumor recurs. Currently, the treatment of laryngeal cancer mostly advocates surgery plus radiotherapy. However, for cancers with a wide range of lesions involving the larynx and a low degree of differentiation, radiotherapy plus surgery is appropriate. The amount of preoperative radiotherapy should be about 4500 cGy, and 2 weeks rest after radiotherapy before surgery. For those who undergo surgery first, if the tumor is excised completely and there is no obvious cervical lymph node metastasis, the total amount of 4500-5000 cGy can be used only for prophylactic irradiation after surgery. For advanced tumor, patient’s condition is poor, and palliative radiotherapy can be used for all stages of cases that are not suitable for surgical treatment. 2.Surgical treatment: Surgery is the main means of laryngeal cancer treatment. Different surgical procedures are often chosen according to the scope of the lesion, biological behavior of the tumor, immunity of the patient and the presence or absence of lymph node metastasis in the neck. The principle of surgery is to preserve or reconstruct the laryngeal articulatory function as much as possible under the premise of radical resection of tumor in order to improve the patient’s survival quality. Chemotherapy: Surgery, radiotherapy and chemotherapy are the three basic treatment methods for head and neck tumors. More than 90% of laryngeal cancers are squamous cell carcinoma, thus the most commonly used drugs are methotrexate (MTX), cis-chloroplatinum (DDP) and bleomycin (BLM). The efficacy of single drug is poor and the side effects are great. At present, most advocate the combination of drugs, the use of chemotherapy induction chemotherapy, adjuvant chemotherapy and palliative chemotherapy and other methods. 4.Immunotherapy: Although there are more reports on immunotherapy in recent years, in general, it is still in the experimental stage and the efficacy has not been confirmed, so it needs to continue to be explored. Immunotherapy includes ? Recombinant cytokines, such as interleukin-2 (IL-2), interferon, tumor necrosis factor (TNF), etc. Relatively transferred immune cells, such as lymphokine-activated killer cells (LAK), tumor-infiltrating lymphocytes (TIL), etc.